Geri
Abbisko Cayman Limited (02256.HK) Fiyatı
02256.HK Hisse Senedi Fiyat Grafiği
ABBISKO-B (02256.HK)
Abbisko Cayman Limited
HK$0
0%
$0
Piyasa Kapalı: Jan 29, 16:00:00 HKT
Henüz Veri YokFollow-Up Questions
Abbisko Cayman Limited'in temel mali tabloları nelerdir?
02256.HK'ün temel finansal oranları nelerdir?
Abbisko Cayman Limited'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Abbisko Cayman Limited kârlı mı?
Abbisko Cayman Limited'in herhangi bir yükümlülüğü var mı?
Abbisko Cayman Limited'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
2.6M
EPS (TTM)
0.25
Dividend yield
--
Piyasa Değeri
--
ABBISKO-B nedir?
Abbisko Cayman Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of drugs and small molecule oncology therapies. The company is headquartered in Shanghai, Shanghai and currently employs 226 full-time employees. The company went IPO on 2021-10-13. The firm is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The firm owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved